Biofeedback for Psoriasis
A Proof-of-Concept Study Exploring HRV-Biofeedback for Psoriasis and Associated Psychological Comorbidities
1 other identifier
interventional
5
1 country
1
Brief Summary
We are conducting a proof-of-concept trial to study the impact of HRV-biofeedback, a mind-body technique designed to improve stress resilience, on the quality of life, mood, and clinical skin severity of patients with psoriasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 7, 2022
CompletedFirst Submitted
Initial submission to the registry
August 16, 2022
CompletedFirst Posted
Study publicly available on registry
August 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedJuly 9, 2024
July 1, 2024
7 months
August 16, 2022
July 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Psoriasis Area and Life Quality Index
11 weeks
Dermatology Life Quality Index
11 weeks
Generalized Anxiety Disorder-7
11 weeks
Patient Health Questionnaire-9
11 weeks
Study Arms (1)
HRV-Biofeedback
EXPERIMENTALInterventions
A 7-week protocol using real-time feedback on heart rate variability
Eligibility Criteria
You may qualify if:
- At least 18 years old
- Diagnosed with or are currently experiencing symptoms of psoriasis
- Located in San Diego or within driving distance
- Have daily access to a smart phone, computer, or tablet
- Able to read and understand English
You may not qualify if:
- High risk of suicidality
- History of chronic kidney disease
- Pacemaker
- Active pregnancy or treatment of cancer or HIV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bastyr University Clinic
San Diego, California, 92101, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2022
First Posted
August 18, 2022
Study Start
June 7, 2022
Primary Completion
December 31, 2022
Study Completion
March 31, 2023
Last Updated
July 9, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share